Consumer opinions on adverse events associated with medicines and vaccines

References

• World Health OrganizationSafety Monitoring of Medicinal Products: Reporting System for the General PublicGenevaWorld Health Organization2012
   Google Scholar
• MatosCHärmarkLvan HunselFPatient reporting of adverse drug reactions: an international survey of national competent authorities’ views and needsDrug Saf2016391105111627581398
   PubMed Web of Science ®Google Scholar
• van HunselFHärmarkLPalSOlssonSvan GrootheestKExperiences with adverse drug reaction reporting by patients: an 11-country surveyDrug Saf201235456022149419
   PubMed Web of Science ®Google Scholar
• TGA eBusiness ServicesAustralian Adverse Drug Reaction Reporting System Available from: https://www.ebs.tga.gov.au/ebs/ADRS/ADRSRepo.nsf?OpenDatabaseAccessed February 27, 2017
   Google Scholar
• Australian Government Department of Health Therapeutic Goods AdministrationReporting adverse drug reactions: information for health professionals2014 Available from: https://www.tga.gov.au/publication/reporting-adverse-drug-reactionsAccessed February 27, 2017
   Google Scholar
• NPS MedicineWiseAdverse Medicine Events Line Available from: https://www.nps.org.au/adverse-medicine-events-lineAccessed February 22, 2018
   Google Scholar
• HärmarkLvan HunselFGrundmarkBADR reporting by the general public: lessons learnt from the Dutch and Swedish systemsDrug Saf20153833734725627832
   PubMed Web of Science ®Google Scholar
• McGuireTMosesGWhat do consumers contribute to pharmacovigilance? Lessons from the AME LineConference Proceedings, National Medicines SymposiumMarch 29–31, 2006Canberra, Australia Available from: http://www.icms.com.au/nms2006/abstract/132.htmAccessed February 27, 2017
   Google Scholar
• RobertsonJNewbyDALow awareness of adverse drug reaction reporting systems: a consumer surveyMed J Aust201319968468624237099
   PubMed Web of Science ®Google Scholar
• FortnumHLeeAJRupnikBAveryAon behalf of the Yellow Card Study CollaborationSurvey to assess public awareness of patient reporting of adverse drug reactions in Great BritainJ Clin Pharm Ther20123716116521592158
   PubMed Web of Science ®Google Scholar
• LorimerSCoxALangfordNJA patient’s perspective: the impact of adverse drug reactions on patients and their views on reportingJ Clin Pharm Ther20123714815221592157
   PubMed Web of Science ®Google Scholar
• ArnottJHesselgreavesHNunnAJWhat can we learn from parents about enhancing participation in pharmacovigilance?Br J Clin Pharmacol2013751109111722905902
   PubMed Web of Science ®Google Scholar
• MargraffFBertramDAdverse drug reaction reporting by patients: an overview of fifty countriesDrug Saf20143740941924748428
   PubMed Web of Science ®Google Scholar
• Australian Government Department of Health Therapeutic Goods AdministrationMedicines and vaccines post-market vigilance: statistics for 2014CanberraTherapeutic Goods Administration2015 Available from: https://www.tga.gov.au/sites/default/files/medicines-and-vaccines-post-market-vigilance-statistics-2014.pdfAccessed March 5, 2017
   Google Scholar
• DeyAWangHQuinnHEHillRMacartneyKKSurveillance of adverse events following immunisation in Australia annual report, 2014Commun Dis Intell Q Rep201640E377E39028278414
   PubMed Web of Science ®Google Scholar
• AndersonCKrskaJMurphyEAveryAon behalf of the Yellow Card Study CollaborationThe importance of direct patient reporting of suspected adverse drug reactions: a patient perspectiveBr J Clin Pharmacol20117280682221496066
   PubMed Web of Science ®Google Scholar
• JarernsiripornkulNPatsureeAKrskaJPublic confidence in ADR identification and their views on ADR reporting: mixed methods studyEur J Clin Pharmacol20177322323127837337
   PubMed Web of Science ®Google Scholar
• van HunselFvan der WelleCPassierAvan PuijenbroekEvan GrootheestKMotives for reporting adverse drug reactions by patient-reporters in the NetherlandsEur J Clin Pharmacol2010661143115020658130
   PubMed Web of Science ®Google Scholar
• Al DweikRStaceyDKohenDYayaSFactors affecting patient reporting of adverse drug reactions: a systematic reviewBr J Clin Pharmacol20178387588327868226
   PubMed Web of Science ®Google Scholar
• MatosCvan HunselFJoaquimJAre consumers ready to take part in the Pharmacovigilance System? – A Portuguese preliminary study concerning ADR reportingEur J Clin Pharmacol20157188389026004569
   PubMed Web of Science ®Google Scholar
• NarumolJArunrotPKrskaJSurvey of patients’ experiences and their certainty of suspected adverse drug reactionsInt J Clin Pharm20153716817425576461
   PubMed Web of Science ®Google Scholar
• KrskaJMorecroftCWPatients’ use of information about medicine side effects in relation to experiences of suspected adverse drug reactions: a cross-sectional survey in medical in-patientsDrug Saf20133667368023700262
   PubMed Web of Science ®Google Scholar
• ChaipichitNKrskaJPratipanawatrTUchaipichatVJarernsiripornkulNA qualitative study to explore how patients identify and assess symptoms as adverse drug reactionsEur J Clin Pharmacol20147060761524531695
   PubMed Web of Science ®Google Scholar
• RolfesLWilkesSvan HunselFvan PuijenbroekEvan GrootheestKImportant information regarding reporting of adverse drug reactions: a qualitative studyInt J Pharm Pract20142223123323937120
   PubMedGoogle Scholar
• KrskaJAndersonCMurphyEAveryAJon behalf of the Yellow Card Study CollaborationHow patient reporters identify adverse drug reactions: a qualitative study of reporting via the UK Yellow Card SchemeDrug Saf20113442943621513365
   PubMed Web of Science ®Google Scholar
• MorganDLKruegerRAThe Focus Group KitThousand Oaks, CASage Publications1998
   Google Scholar
• RubinHJRubinISQualitative Interviewing: The Art of Hearing DataThousand Oaks, CASage Publications1995
   Google Scholar
• TongASainsburyPCraigJConsolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groupsInt J Qual Health Care20071934935717872937
   PubMed Web of Science ®Google Scholar
• KruegerRACaseyMAFocus Groups: A Practical Guide for Applied Research4th edThousand Oaks, CASage Publications2009
   Google Scholar
• BergBLQualitative Research Methods for the Social Sciences6th edBoston, MAPearson/Allyn & Bacon2007
   Google Scholar
• BuchterRBFechtelpeterDKnelangenMEhrlichMWalteringAWords or numbers? Communicating risk of adverse effects in written consumer health information: a systematic review and meta-analysisBMC Med Inform Decis Mak2014147625155972
   PubMed Web of Science ®Google Scholar
• TongVRaynorDKBlalockSJAslaniPConsumer interpretation of ramipril and clopidogrel medication risk information – implications for risk communication strategiesPatient Prefer Adherence2015998398826185427
   PubMed Web of Science ®Google Scholar
• FaasseKGreyAHorneRPetrieKJHigh perceived sensitivity to medicines is associated with higher medical care utilisation, increased symptom reporting and greater information-seeking about medicationPharmacoepidemiol Drug Saf20152459259925851232
   PubMed Web of Science ®Google Scholar
• ParrellaAGoldMBraunack-MayerABaghurstPMarshallHConsumer reporting of adverse events following immunization (AEFI): identifying predictors of reporting an AEFIHum Vaccin Immunother20141074775424406315
   PubMed Web of Science ®Google Scholar
• Australian Government Department of Health Therapeutic Goods AdministrationAustralian statistics on medicines and vaccines 2012CanberraTherapeutic Goods Administration2013 Available from: https://www.tga.gov.au/sites/default/files/medicines-statistics-2012.pdfAccessed March 8, 2017
   Google Scholar
• Australian Government Department of Health Therapeutic Goods AdministrationMedicines and vaccines adverse event reports: statistics for 2013CanberraTherapeutic Goods Administration2014 Available from: https://www.tga.gov.au/sites/default/files/medicines-statistics-2013.pdfAccessed March 8, 2017
   Google Scholar
• Australian Government Department of Health Therapeutic Goods AdministrationMedicines and vaccines post-market vigilance: statistics for 2015CanberraTherapeutic Goods Administration2016 Available from: https://www.tga.gov.au/sites/default/files/medicines-and-vaccines-post-market-vigilance-statistics-2015.pdfAccessed March 8, 2017
   Google Scholar
• SalesIAljadheyHAlbogamiYMahmoudMAPublic awareness and perception toward adverse drug reactions reporting in Riyadh, Saudi ArabiaSaudi Pharm J20172586887228951672
   PubMed Web of Science ®Google Scholar